Craig Garthwaite
Craig Garthwaite

STRATEGY
Associate Professor of Strategy
Co-Director of Health Enterprise Management Program (HEMA)

Print Overview

Professor Garthwaite is an Associate Professor of Strategy and the Co-Director of Kellogg's Health Enterprise Management Program (HEMA). He is an applied microeconomist whose research examines the effects of government policies and social phenomena with a focus on health and biopharmaceutical sectors. His recent work has focused on the private sector effects of the Affordable Care Act, including the labor supply effects of large insurance expansions, the changes in uncompensated hospital care resulting from public insurance expansions, and the responses of non-profit hospitals to financial shocks. In prior work, he has examined the impact of government cash assistance programs on health and the effect of changes in expected mortality from the emergence of crack-cocaine markets on educational attainment.

Professor Garthwaite also studies questions of pricing and innovation in the biopharmaceutical sector. In this area he has examined the effect of expanded patent protection on pricing in the Indian pharmaceutical market, the innovation response of United States pharmaceutical firms to increases in demand, and the relationship between health insurance expansions and high drug prices. 

His research has appeared in journals such as the Quarterly Journal of Economics, the American Economic Review, the Review of Economics and Statistics and Health Affairs and has been profiled in media outlets such as the Wall Street Journal, the Washington Post and Vox. He has also appeared as a guest on various television and radio shows such as Nightly Business Report and NPR Marketplace. In 2015, Professor Garthwaite was named one of Poet and Quants 40 Best under 40 Business School Professors.   

Garthwaite received a B.A. and a Masters in Public Policy from the University of Michigan and his PhD in Economics from the University of Maryland.  Prior to receiving his PhD, he served in a variety of public policy positions including the Director of Research for the Employment Policies Institute. He has testified before the United States House of Representatives and several state legislatures on matters related to the minimum wage and health care reforms.



Print Vita
Education
PhD, 2009, Economics, University of Maryland at College Park
MA, 2008, Economics, University of Maryland at College Park
MPP, 2001, Public Policy, Gerald R. Ford School of Public Policy, University of Michigan
BA, 2000, Political Science, University of Michigan, cum laude

Academic Positions
Assistant Professor of Management and Strategy, Kellogg School of Management, Northwestern University, 2010-present, 2010-present
Senior Lecturer of Management & Strategy, Donald P. Jacobs Scholar, Management & Strategy, Kellogg School of Management, Northwestern University, 2009-present

Other Professional Experience
Director of Research and Chief Economist, Employment Policies Institute, 2003-2005
Economist, Public Sector Consultants, 2002-2003

Honors and Awards
Faculty Impact Teaching Award (2 Sections), Kellogg, One Term
Chairs' Core Course Teaching Award, Kellogg, One Year
Young Economist Award, International Institute of Public Finance, 2011
Impact Award, Kellogg School of Management, 2010

Editorial Positions
Co-Editor, Journal of Public Economics, 2016

Print Research
Research Interests
Health Economics; Pharmaceutical Industry; Public Finance; Political Economy

Articles
Dranove, DavidCraig Garthwaite and Christopher Ody. 2015. Investment Subsidies and the Adoption of Electronic Medical Records in Hospitals. Journal of Health Economics.
Dranove, DavidCraig Garthwaite and Christopher Ody. 2015. The Economic Downturn And Its Lingering Effects Reduced Medicare Spending Growth By $4 Billion In 2009-12. Health Affairs. 34(8): 1368-1375.
Dranove, DavidCraig Garthwaite and Christopher Ody. 2014. Health Spending Slowdown Is Mostly Due To Economic Factors, Not Structural Change In The Health Care Sector. Health Affairs. 33(8): 1399-1406.
Dranove, DavidCraig Garthwaite and Christopher Ody. 2015. Understanding the Lingering Effects of the Economic Downturn on Slowing Medicare Spending Growth. Health Affairs.
Dranove, DavidCraig Garthwaite and Christopher Ody. Forthcoming. How Do Non-Profits Respond to Negative Wealth Shocks? The Impact of the 2008 Stock Market Crash on Hospitals.
Garthwaite, Craig. 2015. Demand Spillovers, Combative Advertising, and Celebrity Endorsements. American Economic Journal: Applied Economics.
Garthwaite, Craig, Tal Gross and Matt Notowidigdo. 2014. Public Health Insurace, Labor Supply, and Employment Lock.. Quarterly Journal of Economics.
Garthwaite, Craig and William Evans. 2013. Giving Mom a Break: The Effect of Higher EITC Payments on Maternal Health. American Economic Journal: Economic Policy.
Garthwaite, Craig and Tim Moore. 2013. Can Celebrity Endorsements Affect Political Outcomes: Evidence from the 2008 US Democratic Presidential Primary. Journal of Law, Economics, & Organization. 29(2): 355-384.
Garthwaite, Craig and William Evans. 2012. Heterogeneity in the Benefits of Greater Treatment Intensity. Review of Economics and Statistics. 94(3): 635-649.
Garthwaite, Craig. 2012. The Doctor Might See You Now: The Supply Side of Public Health Insurance Expansions. American Economic Journal: Economic Policy. 4(3): 190-217.
Garthwaite, Craig. 2012. The Economic Benefits of Pharmaceutical Innovations: The Case of Cox-2 Inhibitors. American Economic Journal: Applied Economics. 4(3): 116-137.
Garthwaite, Craig, William Evans and Heng Wei. 2008. The Impact of Early Discharge Laws on the Health of Newborns. Journal of Health Economics. 27: 843-870.
Working Papers
Dranove, DavidCraig Garthwaite and David Besanko. 2016. The Impact of Health Insurance on Pharmaceuticals Pricing When Consumers Face Liquidity Constraints.
Garthwaite, Craig, William Evans and Tim Moore. Forthcoming. The Black/White Education Gap, Stalled Profess, and the Long-Term Consequences of the Emergence of Crack Markets.
Garthwaite, Craig, matthew notowidigdo and Tal Gross. 2015. Non-Profit Hospitals as Insurers of Last Resort.
Dranove, DavidCraig Garthwaite and Manuel Hermosilla. 2014. Breakthrough or Me-Too? The Impact of Medicare Part D on Biotech Innovation.
Garthwaite, Craig. 2008. The Effect of In-Utero Conditions on Long Term Health: Evidence from the 1918 Spanish Flu Pandemic.
Book Chapters
Garthwaite, Craig and Mark Duggan. 2012. "Empirical Evidence on the Value of Pharmaceuticals." In The [Oxford] Handbook of the Economics of the Biopharmaceutical Industry, 463-492. Oxford, UK: Oxford University Press.
Other
Dranove, DavidCraig Garthwaite and Christopher Ody. "A floor-and-trade proposal to improve the delivery of charity-care services by U.S. nonprofit hospitals." Hamilton Project Discussion Paper.
Cases
Garthwaite, CraigMeghan Busse and Greg Merkley. 2011. Starbucks: A Story of Growth. Case 5-211-259 (KEL665).
Brown, Jennifer, Craig Garthwaite, Susan Crowe, Charlotte Snyder and Greg Merkley. 2016. Global Aircraft Manufacturing, 2002–2011. Case 5-312-505 (KEL938).

 
Print Teaching
Full-Time / Evening & Weekend MBA
Business Strategy (STRT-431-0)
This course was formerly known as MGMT 431
Strategy is the set of objectives, policies and resource commitments that collectively determine how a business positions itself to create wealth for its owners. This course introduces students to principles and conceptual frameworks for evaluating and formulating business strategy. Topics include the boundaries of the firm, the analysis of industry economics, strategic positioning and competitive advantage, and the role of resources and capabilities in shaping and sustaining competitive advantages.

Healthcare Strategy (STRT-945-0)

**This course was formerly known as MGMT-945**

This course delves into the strategic issues faced by healthcare firms. We will use concepts from the core strategy course (STRT-431) as an organizing framework, and discuss where and why the healthcare sector deviates from the norm. For example, what is the role of competitive positioning when quality is so difficult to measure? How can you remain profitable if you compete against not-for-profits who don't face taxes?

Because a great deal of healthcare strategy relies on understanding the nitty-gritty of particular industries, we will spend time learning about several of these, including health insurance, hospitals, pharmaceuticals, and medical devices. Although our focus is on private firms in the U.S., we will (of necessity) be discussing the role of the government in regulating and providing healthcare, and (time permitting) discuss some international issues. This is a lecture and case-based discussion course with group projects and a final exam.



Executive MBA
U.S. Healthcare Strategy (STRTX-945-0)